Tradestie Institutional Equity Comparison Engine
ECAT vs BMEZ โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BMEZ Overall Edge
BMEZ Captures Institutional Edge (1โ0 Pillars ยท 3โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BlackRock Health Sciences Term Trust (BMEZ) driven by superior Momentum & Technical. Fundamentally, ECAT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BMEZ at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ECAT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BMEZ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ECAT N/M vs BMEZ N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
BMEZ
1Y -25.7% vs +13.1% ยท 52W Pos 1% vs 75%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ECAT
NYSE
BlackRock ESG Capital Allocation Term Trust
Institutional Equity
$12.08
-2.97% 1D
Market Cap
$1.6B
1M Return
-8.62%
1Y Return
-25.66%
Forward P/E
N/M
Unified AI Score
33.6 / 100
SELL
Tech 12.0
Fund 40.0
Flow 50.0
Mom 49.0
BMEZ
NYSE
BlackRock Health Sciences Term Trust
Institutional Equity
$16.91
-1.57% 1D
Market Cap
$913.8M
1M Return
+3.81%
1Y Return
+13.11%
Forward P/E
N/M
Unified AI Score
48.2 / 100
HOLD
Tech 46.0
Fund 46.0
Flow 50.0
Mom 31.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ECAT -25.66%
BMEZ +13.11%
Spread: +38.77 pp (BMEZ Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ECAT TTM Op. Margin: N/A
BMEZ TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ECAT vs BMEZ. Trailing 12-month operating profitability (ECAT N/A vs BMEZ N/A) and valuation multiples (ECAT N/M vs BMEZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ECAT | BMEZ | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.6B | $913.8M | Larger Scale | ECAT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 1% ($12โ$16) | 75% ($14โ$18) | Stronger Trend | BMEZ |
| Beta / 30D Volatility Risk Regime | 0.90ฮฒ ยท 28% Vol | 0.63ฮฒ ยท 22% Vol | Lower Realized Risk | BMEZ |
| Unified Institutional Score Composite Signal | 33.6 / 100 (SELL) | 48.2 / 100 (HOLD) | Higher Composite | BMEZ |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ECAT vs BMEZ Buy Guide
ECAT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BMEZ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ECAT nor BMEZ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.